Hardeep Kour, MD
Internal Medicine · San Jose
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
Offices
1 location · Quantum Bay Area Hospitalist Medical Group Inc · 60 clinicians in this group
Hospitals listed: Good Samaritan Hospital. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Kour’s office at (408) 259-5000 to ask if they take your plan before you enroll.
California Medical Board record
Licence A174408 · Current
Licensed to practise in California · since 2021 · expires 2027-08-31 · Jammu University, Acharya Shri Chander College of Medical Sciences.
Matched on the licence number without its letter prefix; check the name before relying on it.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Good Samaritan HospitalSan Jose, CAAcute Care Hospital · Proprietary · Has an emergency department · Birthing-friendlyPart of HCA Healthcare, which runs 185 hospitals in 19 statesPatients rate it 2 of 5 · 67% would definitely recommend itOverall rating: 2 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.337, Oct 2024 – Sep 2025
See every measure and the patient survey for Good Samaritan Hospital
Behind the star rating — Deaths: 0 better, 8 the same, 0 worse of 8 measures. Safety: 1 better, 6 the same, 1 worse of 8 measures. Readmissions: 0 better, 5 the same, 4 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.337 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.75 (0 to 1.67) · 1,340 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.84 (0.54 to 1.14) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 143.59 (98.7 to 188.49) · 98 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.7 · 45 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 100 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12.7 · 270 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 11.3 · 573 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 15.6 · 820 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.5 · 482 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.3 · 3,711 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.12 (0 to 0.3) · 8,866 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.2 (0.01 to 0.38) · 9,051 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 2.65 (0.74 to 4.56) · 1,929 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.8 (0.21 to 3.39) · 670 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.33 (0.88 to 3.78) · 1,836 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 6.73 (0 to 13.46) · 669 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 7.58 (3.96 to 11.19) · 654 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.59 (0.13 to 3.04) · 496 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.27 (0 to 0.87) · 7,373 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.1 · 152 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 1.08 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.542 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.484 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.565 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.8 · 327 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 24.2 · 703 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 61.1 · 289 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 36.3 · 665 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 25.4 · 856 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 19 · 978 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.3 · 144 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 12.3 · 46 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 21.2 · 135 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.8 (10.1 to 18.6) · 129 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.2 (0.9 to 1.5) · 531 cases | No different | Jan 2024 – Dec 2024 |
What patients said (704 patients answered, 24% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 2 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 2 |
| Quietness | 1 |
| Recommend hospital | 3 |
| Room was "always" clean | 66% |
| Nurses "always" communicated well | 75% |
| Doctors "always" communicated well | 71% |
| Staff "always" explained | 54% |
| Yes, staff "did" give patients this information | 83% |
| Yes, staff "did" give patients information about help after discharge | 81% |
| Doctors "always" explained things so they could understand | 66% |
| Doctors "always" listened carefully | 69% |
| Doctors "always" treated them with courtesy and respect | 78% |
| Patients who gave a rating of "9" or "10" (high) | 63% |
| Staff "always" explained new medications | 68% |
| Nurses "always" explained things so they could understand | 69% |
| Nurses "always" listened carefully | 73% |
| Nurses "always" treated them with courtesy and respect | 82% |
| "Always" quiet at night | 38% |
| "YES", patients would definitely recommend the hospital | 67% |
| Staff "always" explained possible side effects | 40% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
Original Medicare doctor bills
$74,832
Medicare paid this office $74,832 for 327 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 194 | $29,807 | $70 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 90 | $17,362 | $106 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 95 | $15,163 | $155 |
| Hospital discharge day management, 30 minutes or less | 82 | $6,219 | $74 |
| Hospital discharge day management, more than 30 minutes | 41 | $4,392 | $105 |
See all 6 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 194 | $29,807 | $70 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 90 | $17,362 | $106 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 95 | $15,163 | $155 |
| Hospital discharge day management, 30 minutes or less | 82 | $6,219 | $74 |
| Hospital discharge day management, more than 30 minutes | 41 | $4,392 | $105 |
| Advance care planning, first 30 minutes | 19 | $1,360 | $68 |
Who their Medicare patients are
327 Original Medicare patients in 2024. Average age 79 · Under 65 6% · 85 and older 29% · Women 53% · Also on Medicaid 50% · Health risk score 2.60. Above the middle of the specialty; the typical internal medicine clinician is at 1.76.
Conditions among them: High blood pressure 75% · Diabetes 54% · Coronary heart disease 48% · Chronic kidney disease 48% · Heart failure 46% · Atrial fibrillation 44% · Dementia 35% · Depression 31% · Stroke 31% · COPD 26% · Cancer 20%.
The office billed $308,620, Medicare allowed $93,967 and paid $74,832; for 837 services of 8 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 327 | 837 | 79 | 2.60 | $308,620 | $74,832 |
| 2023 | 306 | 540 | 78 | 2.23 | $234,388 | $56,412 |
| 2022 | 139 | 154 | 77 | 1.82 | $87,599 | $22,183 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 5 services
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 151 | $25,157 | $157 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 122 | $15,399 | $71 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 56 | $8,146 | $107 |
| Hospital discharge day management, 30 minutes or less | 57 | $4,228 | $74 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 25 | $3,067 | $118 |
2022: 2 services
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 89 | $16,251 | $177 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 24 | $2,341 | $94 |
Medicaid work
$1,325 in 2024
Medicaid paid $1,325 for 129 billed services this clinician did in 2024, up to 25 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 103 | $780 |
| 1ST HOSP IP/OBS HIGH 75 | 26 | $545 |
| 2024 | 129 | 2 | 25 | $1,325 |
| 2023 | 118 | 2 | 16 | $1,629 |
| 2022 | 2,043 | 8 | 139 | $107,955 |
| 2021 | 233 | 5 | 80 | $14,853 |
See the largest Medicaid services in earlier years
2023
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 90 | $1,049 |
| 1ST HOSP IP/OBS HIGH 75 | 28 | $580 |
2022
| Clinic visit/encounter, all-inclusive | 676 | $104,413 |
| 1ST HOSP IP/OBS HIGH 75 | 56 | $1,752 |
| Short return visit (20+ min) | 638 | $780 |
| New patient visit (45+ min) | 423 | $689 |
| Initial comprehensive preventive medicine evaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, new patient; 18-39 years | 92 | $126 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 12 | $92 |
| New patient visit (30+ min) | 100 | $57 |
| Return visit (30+ min) | 46 | $47 |
2021
| Clinic visit/encounter, all-inclusive | 90 | $14,426 |
| New patient visit (45+ min) | 24 | $207 |
| New patient visit (30+ min) | 75 | $172 |
| Short return visit (20+ min) | 22 | $48 |
| Initial comprehensive preventive medicine evaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, new patient; 40-64 years | 22 | $0 |
Drugs they prescribed that Part D paid
$21,314
Pharmacies billed $21,314 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
177 generic and 27 brand-name prescriptions · $21,314 in drug cost · 28 antibiotic prescriptions to 24 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Lisinopril | 13 | $268 | $21 |
| Metoprolol | 17 | $101 | $6 |
| Amoxicillin-Clavulanate Potass | 12 | $62 | $5 |
Year by year
| 2024 | 204 | 88 | None | 13% | $21,314 |
| 2023 | 176 | 74 | None | None | $23,751 |
| 2022 | 317 | 63 | None | None | $44,927 |
| 2021 | 422 | 77 | 0% (0) | 15% | $28,886 |
| 2020 | 496 | 97 | 0% (0) | None | $33,498 |
| 2019 | 280 | 71 | 0% (0) | None | $22,608 |
| 2018 | 52 | 19 | 0% (0) | 25% | $5,873 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 2 drugs
| Lisinopril | 19 | $145 | $8 |
| Metoprolol | 12 | $63 | $5 |
2022: 7 drugs
| Januvia | 13 | $21,982 | $1,691 |
| Atorvastatin | 23 | $543 | $24 |
| Metformin | 29 | $450 | $16 |
| Amlodipine Besylate | 18 | $370 | $21 |
| Diclofenac | 12 | $323 | $27 |
| Lisinopril | 33 | $256 | $8 |
| Losartan | 11 | $183 | $17 |
2021: 8 drugs
| Atorvastatin | 22 | $553 | $25 |
| Omeprazole | 15 | $290 | $19 |
| Fluticasone Propionate | 11 | $276 | $25 |
| Levothyroxine | 16 | $198 | $12 |
| Metformin | 17 | $151 | $9 |
| Pantoprazole | 13 | $85 | $7 |
| Cyclobenzaprine | 11 | $64 | $6 |
| Furosemide | 11 | $29 | $3 |
2020: 11 drugs
| Fluticasone Propionate | 36 | $652 | $18 |
| Atorvastatin | 26 | $285 | $11 |
| Carvedilol | 26 | $217 | $8 |
| Levothyroxine | 12 | $200 | $17 |
| Montelukast | 14 | $187 | $13 |
| Amlodipine Besylate | 34 | $186 | $5 |
| Pantoprazole | 27 | $182 | $7 |
| Lisinopril | 22 | $156 | $7 |
| Metformin | 16 | $124 | $8 |
| Furosemide | 15 | $112 | $7 |
| Metformin Hcl Er | 11 | $70 | $6 |
2019: 3 drugs
| Atorvastatin | 17 | $309 | $18 |
| Carvedilol | 15 | $114 | $8 |
| Amlodipine Besylate | 31 | $94 | $3 |
Money from drug and device companies
$124 in 2022
| 2022 | 1 | 1 | None | $124 |
| 2021 | 2 | 2 | None | $30 |
| 2020 | 1 | 1 | None | $15 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Alexion Pharmaceuticals | Soliris | $124 | 1 payment
|
See the published payment
| Alexion Pharmaceuticals | Meals · 2022-12-01 | Soliris | $124 |
See earlier years (2021, 2020)
2021: $30
| Novo Nordisk | Rybelsus | $19 | 1 payment
|
| Lilly USA | Trulicity | $11 | 1 payment
|
2020: $15
| Lilly USA | Trulicity | $15 | 1 payment
|
Professional record
- NPI
- 1477059491
- Licence
- CA 174408California A174408: Current · expires 2027-08-31
- Gender
- Female
More record details
- Sole proprietor
- Yes
- Taxonomy
- Internal medicine (207R00000X); Student in a training program (390200000X)
- Mailing address
- 4923 Esguerra Ter, Fremont, CA, 94555
- NPI first listed
- 2018-03-30
- NPI last updated
- 2021-09-15
- NPI record certified
- 2021-09-15
This is when the NPI record was last certified, not a medical board exam.